US Pharma MarketingJ&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout
J&J strikes its deal with Sail as the in vivo CAR-T space becomes increasingly crowded, with several big pharma players betting on the class.
J&J strikes its deal with Sail as the in vivo CAR-T space becomes increasingly crowded, with several big pharma players betting on the class.
Source: Pharmaceutical Technology